期刊文献+

真武汤对心力衰竭大鼠心肌中小G蛋白的影响 被引量:2

Influence of Zhenwu Decoction on small G protein in cardiac muscle of Heart Failure
原文传递
导出
摘要 目的通过超声检测,使真武汤在治疗冠心病后心衰的效果更直观,探讨其机制并明确的指导临床用药。方法选取健康雄性wistar大鼠60只,随机选取50只按大鼠进行心梗后心力衰竭造模手术。把造模大鼠随机平均分成5组,分别为模型组,真武汤组(高、中、低剂量),卡托普利组,其余10只为空白对照组。将这些大鼠分别灌胃15天进行超声检测,计算出左室短轴缩短率(LVFS)与左室射血分数(LVEF)。取样本用westen blot技术检测心肌中小G蛋白相关变化。结果高剂量真武汤组LVFS与LVEF值较模型组相比改善,P<0.01有统计学意义;高剂量组灌胃的大鼠小G代表灰度值表达趋势降低,P<0.01。说明真武汤可以减少小G的活化,真武汤可以缓解心衰患者临床症状,改善心功能。 Objective By echocardiograph,the effect of Zhenwu Decoction is more intuitive in treating heart failure,Clear guidance for clinica. Methods Selecting 60 male wistar rats,We randomly selected 50 male wistar rats building operation,being heart failure after heart attack. The rats were randomly assigned to five groups,For the model group,the Zhenwu Decoction group( Zhenwu Decoction high-dose,moderate-dose,low-dose groups),the captopril group,the other 10 rats were just blank control groups. This group rats were given by gavage once a day for 15 d. The blank group was filled with saline. By echocardiograph,to calculatet the LVFS and LVEF. The sample was used to detect changes small G protein in the heart muscle of the westen blot technique. Results The high-dose group's LVFS and LVEF were significantly better than the model group,P 0. 01,has statistical significance. The high-dose group's rat's small G protein show significantly lower trends,P 0. 01. Zhenwu Decoction is not onlyeffective in alleviating clinical symptoms,but also improving the function of the heart.
作者 陆宁 李文杰
出处 《辽宁医学杂志》 2017年第4期1-3,共3页 Medical Journal of Liaoning
基金 国家自然科学基金面上项目(81173184)
关键词 真武汤 心衰 小G蛋白 Zhenwu Decoction Heart failure Small G protein
  • 相关文献

参考文献5

二级参考文献94

  • 1李小鹰.慢性心力衰竭的治疗:从治疗指南到临床实践[J].中华内科杂志,2005,44(7):484-485. 被引量:37
  • 2姜蓉.中医辩证治疗椎-基底动脉缺血性眩晕54例[J].海南医学,2006,17(9):153-153. 被引量:2
  • 3程晓昱,胡业彬,葛岚,王怀美,姚淮芳,汪健,张业祥,杜卫甫,刘峰.益气温阳活血法对慢性充血性心力衰竭患者神经内分泌的影响[J].中国中医急症,2007,16(3):253-254. 被引量:8
  • 4Sussman MA, Welch S, Walker A, et al. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active racl [J]. J Clin Invest,2000,105(7) :875-886.
  • 5Hoshijima M, Sah VP, Wang Y, et al. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular cardiomyocytes, involvement of Rho Kinase [J]. J Biol Chem,1998,273:7725-7730.
  • 6Hunter JJ, Tanaka N, Rockman HA, et al. Ventricular expression of a MLC-2-v-ras fusion induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice [ J ]. J Biol Chem, 1995,270,23173-23178.
  • 7Sah VP, Minami~wa S, Tan SP, et al. cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure [ J ]. J Clin Invest, 1999, 103 ( 12 ) : 1627-1634.
  • 8Patel R, Nagueh SF, Tsybouleva N. Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy [ J ]. Circulation, 2001,104 ( 3 ) :317-324.
  • 9Clerk A, Pham FH, Stephen J. Regulation of Mitogen-Activated Protein Kinases in Cardiac Myocytes through the Small G Protein Racl [ J]. Mol Cell Bio1,2001, 21 (4) : 1173-1184.
  • 10Xiao L, Pimental DR, Amin JK, et al. MEK1/2-ERK1/2 mediates al-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes[ J]. J Mol Cell Cardio1,2001,33(4) :779-787.

共引文献23

同被引文献69

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部